Prelude Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$226K Buy
+558
New +$226K 0.02% 745
2024
Q4
Sell
-349
Closed -$216K 1445
2024
Q3
$216K Sell
349
-306
-47% -$189K 0.01% 924
2024
Q2
$362K Buy
655
+129
+25% +$71.3K 0.03% 624
2024
Q1
$306K Buy
+526
New +$306K 0.02% 791
2023
Q4
Sell
-3,856
Closed -$1.95M 1224
2023
Q3
$1.95M Buy
3,856
+1,390
+56% +$704K 0.13% 163
2023
Q2
$1.29M Buy
2,466
+2,034
+471% +$1.06M 0.08% 237
2023
Q1
$249K Sell
432
-39
-8% -$22.5K 0.01% 663
2022
Q4
$259K Sell
471
-707
-60% -$389K 0.01% 740
2022
Q3
$597K Buy
1,178
+233
+25% +$118K 0.02% 575
2022
Q2
$513K Sell
945
-3,047
-76% -$1.65M 0.01% 670
2022
Q1
$2.36M Buy
+3,992
New +$2.36M 0.07% 214
2021
Q4
Sell
-2,058
Closed -$1.18M 1912
2021
Q3
$1.18M Buy
2,058
+699
+51% +$399K 0.03% 345
2021
Q2
$686K Buy
+1,359
New +$686K 0.02% 621
2021
Q1
Hold
0
1383
2020
Q4
Sell
-479
Closed -$211K 1528
2020
Q3
$211K Buy
+479
New +$211K 0.01% 486
2019
Q3
Sell
-303
Closed -$89K 1566
2019
Q2
$89K Buy
+303
New +$89K ﹤0.01% 669
2019
Q1
Sell
-4,307
Closed -$964K 1728
2018
Q4
$964K Buy
+4,307
New +$964K 0.06% 200
2016
Q4
Sell
-3,107
Closed -$494K 1715
2016
Q3
$494K Sell
3,107
-214
-6% -$34K 0.05% 281
2016
Q2
$491K Buy
3,321
+257
+8% +$38K 0.07% 260
2016
Q1
$434K Sell
3,064
-2,678
-47% -$379K 0.06% 284
2015
Q4
$815K Buy
5,742
+3,178
+124% +$451K 0.13% 167
2015
Q3
$314K Sell
2,564
-4,848
-65% -$594K 0.05% 371
2015
Q2
$962K Buy
7,412
+1,404
+23% +$182K 0.13% 174
2015
Q1
$807K Buy
6,008
+698
+13% +$93.8K 0.11% 218
2014
Q4
$665K Buy
5,310
+1,440
+37% +$180K 0.1% 213
2014
Q3
$471K Hold
3,870
0.07% 360
2014
Q2
$457K Buy
3,870
+1,300
+51% +$154K 0.06% 363
2014
Q1
$309K Buy
2,570
+1,870
+267% +$225K 0.04% 512
2013
Q4
$78K Buy
+700
New +$78K 0.01% 868
2013
Q3
Sell
-600
Closed -$51K 1689
2013
Q2
$51K Buy
+600
New +$51K 0.01% 731